Clinically deployable Kinesia™ technology for automated tremor assessment

The objective was to design, build, and assess Kinesia™, a wireless system for automated assessment of Parkinson's disease (PD) tremor. The current standard in evaluating PD is the Unified Parkinson's Disease Rating Scale (UPDRS), a qualitative ranking system typically completed during an...

Full description

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 24; no. 5; pp. 723 - 730
Main Authors Giuffrida, Joseph P., Riley, David E., Maddux, Brian N., Heldman, Dustin A.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 15.04.2009
Wiley
Subjects
Online AccessGet full text
ISSN0885-3185
1531-8257
1531-8257
DOI10.1002/mds.22445

Cover

More Information
Summary:The objective was to design, build, and assess Kinesia™, a wireless system for automated assessment of Parkinson's disease (PD) tremor. The current standard in evaluating PD is the Unified Parkinson's Disease Rating Scale (UPDRS), a qualitative ranking system typically completed during an office visit. Kinesia integrates accelerometers and gyroscopes in a compact patient‐worn unit to capture kinematic movement disorder features. Objectively quantifying PD manifestations with increased time resolution should aid in evaluating efficacy of treatment protocols and improve patient management. In this study, PD subjects performed the tremor subset of the UPDRS motor section while wearing Kinesia. Quantitative kinematic features were processed and highly correlated to clinician scores for rest tremor (r2 = 0.89), postural tremor (r2 = 0.90), and kinetic tremor (r2 = 0.69). The quantitative features were used to develop a mathematical model that predicted tremor severity scores for new data with low errors. Finally, PD subjects indicated high clinical acceptance. © 2009 Movement Disorder Society
Bibliography:National Institute of Neurological Disorders and Stroke
Potential conflict of interest: Dr. Giuffrida and Dr. Heldman are employess of CleveMed.
Phase II SBIR - No. 5R44NS043816-03
ark:/67375/WNG-2J9KJGDQ-R
National Institutes of Health
ArticleID:MDS22445
istex:5E3ECD49515AA95782467635A7EEFFE83BEF1245
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0885-3185
1531-8257
1531-8257
DOI:10.1002/mds.22445